IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
180 hedge funds and large institutions have $691M invested in Immunogen Inc in 2017 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
26% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 58
Holders
180
Holding in Top 10
1
Calls
$5.99M
Puts
$5.38M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$21.8M | |
| 3 | +$21.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$15.6M |
| 5 |
O
OrbiMed
New York
|
+$11.6M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$4.85M | |
| 3 | -$3.59M | |
| 4 |
Goldman Sachs
New York
|
-$3.35M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.5M |